scholarly article | Q13442814 |
P2093 | author name string | Jean Bennett | |
P433 | issue | 2 | |
P921 | main subject | gene therapy | Q213901 |
P1104 | number of pages | 3 | |
P304 | page(s) | 177-179 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Human Gene Therapy | Q15757580 |
P1476 | title | Commentary: an aye for eye gene therapy | |
P478 | volume | 17 |
Q36708300 | AAV-mediated gene transfer for retinal diseases |
Q33397385 | Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. |
Q35594134 | Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. |
Q37731899 | Drug and gene delivery to the back of the eye: from bench to bedside. |
Q33267297 | Efficient non-viral ocular gene transfer with compacted DNA nanoparticles |
Q36099346 | Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors |
Q44953303 | Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. |
Q36545533 | Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. |
Q42019986 | Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria |
Q36965152 | Versatility of AAV vectors for retinal gene transfer |
Q84748042 | WITHDRAWN: Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria |
Search more.